浅析静脉药物配置中心不合理用药问题主要类型及其解决对策  

The Main Problem Types of Unreasonable Medication of Intravenous Drug Configuration Centers and Their Solutions to the Countermeasures

作　　者：芮月琴 吴佳伟[1] RUI Yueqin;WU Jiawei(Suzhou Wuzhong District People's Hospital Suzhou,Jiangsu 215128)

机构地区：[1]苏州市吴中区人民医院,江苏苏州215128

出　　处：《智慧健康》2025年第2期124-127,共4页Smart Healthcare

摘　　要：目的评估静脉药物配置中心不合理用药问题的主要类型及其解决对策。方法将2022年1—12月本院静脉药物配置中心的300份医嘱处方纳入对照组;对2023年1—12月本院静脉药物配置中心的300份医嘱处方采取针对性干预对策,并将其纳入观察组。对比分析两组的不合理用药发生率和患者满意率。结果常见不合理用药事件包含超剂量用药、溶剂使用不当、重复给药、超适应证用药、配伍不当等,上述情况的发生率观察组明显较对照组更低,患者满意率则明显高于对照组,统计学上具有显著意义(P<0.05)。结论在静脉药物配置中心,不合理用药情况时有发生。但对其加强干预,可明显降低不合理用药发生率,从而保障临床用药的安全性。Objective To evaluate the main problems of the unreasonable medication and intervention countermeasures of the intravenous drug configuration center.Methods Select 300 medical prescriptions of the hospital's intravenous drug configuration center from January 2022 to December 2022 as the control group.The 300 doctor's order prescription adopts targeted intervention countermeasures and sets it as an observation group to compare and analyze the incidence of unreasonable medication and patient satisfaction rate of the two groups.Results Analysis can be seen that common and unreasonable medication events include ultra-doses of medication,improper solvent use,repeated medication,super suitable medication,improper compatibility,etc.The incidence of the above situation is sig nificantly lower than that of the control group,and the patient satisfaction rate is obviously obvious.Highly higher than the control group,statistically significant significance(P<0.05).Conclusion The unreasonable medication phenomenon of intravenous drug configuration centers is more frequent.By strengthening intervention,it can significantly reduce the incidence of unreasonable medication,thereby ensuring the safety of clinical medication.

关 键 词：静脉药物 配置中心 不合理用药 问题类型 解决对策 

分 类 号：R47[医药卫生—护理学]